Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener's)

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Garske, Ulrike ^a   Haack, Andrea ^a   Beltrán, Olga ^b   Flores Suárez, Louis F ^c   Bremer, Jan P ^d   Lamprecht, Peter ^d   Hedderich, Jürgen ^e   Quetz, Joachim ^a   Gross, Wolfgang L ^d   Ambrosch, Petra ^a   Laudien, Martin ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^c INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Activity score; ANCA; ENT; ENTAS; Granulomatosis with polyangiitis; Nose; Wegener's

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CORRELATION COEFFICIENT; DISEASE ACTIVITY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MALE; NOSE DISEASE; NOSE MUCOSA; PLASTIC SURGERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

ADULT; AGED; CLINICAL COMPETENCE; ENDOSCOPY; FEMALE; GERMANY; HUMANS; MALE; MEXICO; MIDDLE AGED; NASAL CAVITY; NASAL MUCOSA; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; WEGENER GRANULOMATOSIS;

EID: 84863761388     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. KLINGER H: Grenzformen der Periarteriitis nodosa. Frankfurter Zeitschrift für Pathologie 1931; 42: 455-80.
2. WEGENER F: Über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren. Beitr Pathol Anatom 1939; 102: 36-68.
3. LAUDIEN M, AMBROSCH P, TILL A, PODSCHUN R, LAMPRECHT P: [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement]. Z Rheumatol 2008; 67: 397-406.
4. SUPPIAH R, FLOSSMAN O, MUKHTYAR C et al.: Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. Ann Rheum Dis 2011; 70: 80-5.
5. HOLLE JU, GROSS WL, HOLL-ULRICH K et al.: Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 2010; 69: 1934-43.
6. HUI Y, WOHLERS J, PODSCHUN R et al.: Antimicrobial peptides in nasal secretion and mucosa with respect to S. aureus colonisation in Wegener's granulomatosis. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S49-S56.
7. LAUDIEN M, HASLER R, WOHLERS J et al.: Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol 2011; 4: 564-73.
8. LAUDIEN M: Nasal barrier dysfunction in Wegener's granulomatosis. Clin Exp Rheumatol 2010; 28 (Suppl. 57): 3-4.
9. LAUDIEN M, GADOLA SD, PODSCHUN R et al.: Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener's granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol 2010; 28 (Suppl. 57): 51-5.
10. ULLRICH S, GUSTKE H, LAMPRECHT P et al.: Severely impaired respiratory ciliar function in Wegener's Granulomatosis. Ann Rheum Dis 2008.
11. DEL BUONO EA, FLINT A: Diagnostic usefulness of nasal biopsy in Wegener's granulomatosis. Hum Pathol 1991; 22: 107-10.
12. FAUCI AS, HAYNES BF, KATZ P, WOLFF SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
13. VAN DER WOUDE FJ, RASMUSSEN N, LOBATTO S et al.: Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-9.
14. REINHOLD-KELLER E, BEUGE N, LATZA U et al.: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000; 43: 1021-32.
15. DE GROOT K, GROSS WL, HERLYN K, REINHOLD-KELLER E: Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001; 55: 31-8.
16. HELLMICH B, FLOSSMANN O, GROSS WL et al.: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-17.
17. WHITING-O'KEEFE QE, STONE JH, HELLMANN DB: Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 1999; 42: 2365-71.
18. PIRSIG W, PENTZ S, LENDERS H: Repair of saddle nose deformity in Wegener's granulomatosis and ectodermal dysplasia. Rhinology 1993; 31: 69-72.
19. QUETZ J. SATTELNASE BEI M. WEGENER F: Rekonstruktive Rhinoplastik mit autologen Rippenknorpetransplantaten durch geschlossene Technik. Germans Medical Science (gms). 2008.
20. LUQMANI RA: Assessing disease activity in the systemic vasculitides. Curr Opin Rheumatol 2002; 14: 23-8.
21. PAULSEN JI, RUDERT H: [Manifestations of primary vasculitis in the ENT region]. Z Rheumatol 2001; 60: 219-25.
22. GAMAR M, LEMON J, SING IFP: IRR: Various Coefficients of Interrater Reliability and Agreement. R package version 0.83. 2010.
23. R Development Core Team.R. A Language and Environment for Statistical Computing. 2011.
24. LITTLE MA, NIGHTINGALE P, VERBURGH CA et al.: Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 2010; 69: 1036-43.
25. HOLLE JU, GROSS WL, LATZA U et al.: Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 2011; 63: 257-66.
26. DEVANEY KO, TRAVIS WD, HOFFMAN G, LEAVITT R, LEBOVICS R, FAUCI AS: Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 1990; 14: 555-64.
27. JENNINGS CR, JONES NS, DUGAR J, POWELL RJ, LOWE J: Wegener's granulomatosis-a review of diagnosis and treatment in 53 subjects. Rhinology 1998; 36: 188-91.
28. HOLL-ULRICH K, REINHOLD-KELLER E, MULLER A, FELLER AC: [Pathology of vasculitis: differential diagnosis and selected disorders]. Verh Dtsch Ges Pathol 2002; 86: 83-90.
29. MERKEL PA, CUTHBERTSON DD, HELLMICH B et al.: Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. Ann Rheum Dis 2009; 68: 103-6.
30. MUKHTYAR C, LEE R, BROWN D et al.: Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009; 68: 1827-32.
31. SUPPIAH R, MUKHTYAR C, FLOSSMANN O et al.: A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology 2011; 50: 899-905.
32. LUQMANI RA, BACON PA, MOOTS RJ et al.: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.